 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Glaxo Plans Another Price Cut in AIDS Drugs to Poor CountriesJune 11, 2001 GlaxoSmithKline PLC will announce today another round of price reductions for AIDS drugs in poor countries. The list price for three AIDS drugs -- Ziagen, Trizivir and Agenerase -- will be reduced to cost in 63 of the world's poorest countries. But even at those discounts, Jean-Pierre Garnier, Glaxo's chief executive, admitted the prices will keep the drugs out of reach for most patients. Wall Street Journal 06.11.01; Rachel Zimmerman  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
